Year To Quarter End Statement Of Income

株式会社ＰＲＩＳＭ　ＢｉｏＬａｂ - Filing #7333205

Concept	2023-10-01 to 2024-03-31	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30	2022-10-01 to 2023-09-30	2021-10-01 to 2022-09-30	2021-10-01 to 2022-09-30	2021-10-01 to 2022-09-30	2021-10-01 to 2022-09-30
Year to quarter end statement of income
Statement of income
Net sales	115,482,000 JPY	—	112,926,000 JPY	—	—	554,396,000 JPY	—	—	—
Cost of sales	45,091,000 JPY	—	32,620,000 JPY	—	—	19,259,000 JPY	—	—	—
Gross profit (loss)	70,391,000 JPY	—	80,305,000 JPY	—	—	535,136,000 JPY	—	—	—
Selling, general and administrative expenses	404,723,000 JPY	—	577,174,000 JPY	—	—	468,454,000 JPY	—	—	—
Selling, general and administrative expenses
Operating profit (loss)	-334,331,000 JPY	—	-496,868,000 JPY	—	—	66,681,000 JPY	—	—	—
Non-operating income
Interest income	12,000 JPY	—	19,000 JPY	—	—	21,000 JPY	—	—	—
Non-operating income	16,726,000 JPY	—	89,000 JPY	—	—	13,960,000 JPY	—	—	—
Non-operating expenses
Non-operating expenses	—	—	770,000 JPY	—	—	1,976,000 JPY	—	—	—
Ordinary profit (loss)	-322,855,000 JPY	—	-497,550,000 JPY	—	—	78,666,000 JPY	—	—	—
Extraordinary losses
Impairment losses	12,593,000 JPY	—	28,151,000 JPY	—	—	4,508,000 JPY	—	—	—
Extraordinary losses	12,593,000 JPY	—	28,154,000 JPY	—	—	4,508,000 JPY	—	—	—
Profit (loss) before income taxes	-335,448,000 JPY	—	-525,704,000 JPY	—	—	74,157,000 JPY	—	—	—
Income taxes - current	604,000 JPY	—	1,210,000 JPY	—	—	1,210,000 JPY	—	—	—
Income taxes - deferred	—	—	JPY	—	—	-15,000 JPY	—	—	—
Income taxes	604,000 JPY	—	1,210,000 JPY	—	—	1,194,000 JPY	—	—	—
Profit (loss)	-336,052,000 JPY	-526,914,000 JPY	-526,914,000 JPY	-526,914,000 JPY	-526,914,000 JPY	72,962,000 JPY	72,962,000 JPY	72,962,000 JPY	72,962,000 JPY